Rafferty Asset Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.49M Sell
69,505
-25,327
-27% -$1.79M 0.02% 423
2025
Q4
$6.38M Sell
94,832
-13,382
-12% -$900K 0.02% 352
2025
Q3
$7.94M Sell
108,214
-72,452
-40% -$4.81M 0.03% 330
2025
Q2
$9.4M Buy
180,666
+67,377
+59% +$3.83M 0.03% 285
2025
Q1
$7.23M Sell
113,289
-106,103
-48% -$6.16M 0.03% 305
2024
Q4
$10.5M Buy
219,392
+30,852
+16% +$1.58M 0.04% 278
2024
Q3
$10.8M Buy
188,540
+54,437
+41% +$3.12M 0.04% 276
2024
Q2
$7.02M Sell
134,103
-85,649
-39% -$3.76M 0.03% 341
2024
Q1
$8.94M Sell
219,752
-4,972
-2% -$186K 0.03% 304
2023
Q4
$8.31M Sell
224,724
-6,468
-3% -$244K 0.04% 329
2023
Q3
$8.83M Sell
231,192
-13,353
-5% -$547K 0.05% 255
2023
Q2
$8.82M Buy
244,545
+81,102
+50% +$2.77M 0.05% 234
2023
Q1
$6.24M Buy
163,443
+21,840
+15% +$1.02M 0.04% 334
2022
Q4
$8.06M Sell
141,603
-25,692
-15% -$1.32M 0.07% 259
2022
Q3
$6.62M Buy
167,295
+80,143
+92% +$3.54M 0.07% 242
2022
Q2
$3.83M Sell
87,152
-66,844
-43% -$2.89M 0.04% 339
2022
Q1
$6.14M Buy
153,996
+1,153
+0.8% +$41.1K 0.04% 322
2021
Q4
$6.15M Buy
152,843
+77,287
+102% +$2.89M 0.03% 292
2021
Q3
$3.07M Buy
75,556
+14,592
+24% +$610K 0.02% 465
2021
Q2
$2.77M Sell
60,964
-14,122
-19% -$625K 0.02% 532
2021
Q1
$3.13M Buy
75,086
+52,376
+231% +$2.39M 0.02% 459
2020
Q4
$970K Sell
22,710
-50,641
-69% -$1.82M 0.01% 504
2020
Q3
$1.93M Buy
73,351
+31,506
+75% +$877K 0.02% 426
2020
Q2
$1.12M Buy
+41,845
New +$944K 0.02% 510
2020
Q1
Sell
-81,544
Closed -$1.45M 691
2019
Q4
$1.45M Sell
81,544
-75,034
-48% -$1.3M 0.02% 464
2019
Q3
$2.43M Buy
156,578
+21,271
+16% +$350K 0.04% 291
2019
Q2
$2.33M Buy
135,307
+29,758
+28% +$480K 0.04% 342
2019
Q1
$1.7M Buy
+105,549
New +$1.71M 0.03% 444

Other funds holding HALO

Rafferty Asset Management's HALO Position: Q1 2026 in Review

Rafferty Asset Management reduced its Halozyme (HALO) stake by 27% in Q1 2026, selling an estimated $1.79M and leaving 69,505 shares worth $4.49M. The position accounts for 0.02% of the portfolio, ranked #423.

Rafferty Asset Management first reported a position in HALO in Q1 2019 and has held it in 28 quarters since. The position peaked at $10.8M in Q3 2024. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • Rafferty Asset Management held 69,505 shares of Halozyme worth $4.49M as of Q1 2026.
  • Rafferty Asset Management sold 25,327 Halozyme shares in Q1 2026, an estimated $1.79M.
  • Halozyme made up 0.02% of Rafferty Asset Management's portfolio in Q1 2026, its #423 holding.
  • Rafferty Asset Management first reported a position in Halozyme in Q1 2019 and has held it in 28 quarters since.
  • Rafferty Asset Management's Halozyme position peaked at $10.8M in Q3 2024.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Rafferty Asset Management's 13F filing for Q1 2026, filed 15 May 2026.